Stefano Baila received his PhD in 2007 based upon translational research and development of gene therapies for hemophilia at the Children’s Hospital of Philadelphia. Since that time he has been actively involved in the process development and manufacturing of advanced therapeutic medicinal products through business development and strategic marketing roles at Areta International, a CDMO, and by leading field implementation and commercialization activities for the cell processing unit of Terumo BCT. Stefano also worked as Industrialization Manager at Celyad where he led process development and automation efforts for CAR-T therapeutics. Now he serves as Director of Operation and Business Development for Anemocyte
Founder and CEO of Adva Biotechnology a company developing a state of the art automated autologous manufacturing system. A well-known international expert in cell therapy with extensive knowledge of the industry. Dr Karnieli was the founder and President of Atvio Biotech, a leading Innovation center for cell and gene therapy. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP medical device at Goji solutions. Dr Karnieli served as the chair of several industry committees such as the process & product development committee of the International Society for Cellular Therapies, expert member in the ISO TC276 Biotechnology standard committee and the former chair of the science and technology committee of the Alliance for Regenerative Medicine. Furthermore, Dr Karnieli serves as an advisor and board member to several of the lead cell therapy developing companies. Dr Karnieli earned his PhD on Cell and Gene Therapy in the Sackler School of Medicine of the Tel Aviv University. Furthermore, he holds an MBA from the Haifa University business management school.
Ivan Wall is Professor of Regenerative Medicine, Cell and Gene Therapy Bioprocessing at Aston University in Birmingham, UK. He obtained his PhD in cell and molecular biology of wound healing from Cardiff University (2007) and subsequently took postdoctoral research posts at the Eastman Dental Institute and the Institute of Ophthalmology, both at University College London (UCL). He obtained his first academic post at UCL in the Department of Biochemical Engineering (2009-2017), progressing from Lecturer to Reader (Associate Professor) before taking up his current post. His research interests span bioprocess and analytical development for advanced therapy products and have been enabled through numerous collaborations with academic and industry partners around the world. He has published 70 papers to date and has been a visiting professor at Dankook University in South Korea since 2010. With partners in the UK and Ireland he has recently established a Centre for Doctoral Training that focusses on technologies for advancing regenerative medicine.